AGTR1 and neoplasm: Interestingly, K. Yang et al. (116) revealed that, in the human NSCLC cell, Ang II/AT1R signalling was able to suppress anti-tumour immunity through the activation of programmed death ligand-1 expression, which inhibits T-cell activity in the tumour microenvironment (116).